Lipocine (LPCN) Accounts Payables (2011 - 2025)
Lipocine's Accounts Payables came in at $971,822 for Q4 2025, up 257.7% from $271,696 a year earlier and up 12.8% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Accounts Payables (2011 - 2025) Analysis & Trends
Going back to Q4 2011, Lipocine's Accounts Payables data covers 56 quarters.
- Accounts Payables carries a five-year compound annual growth rate of -9.5% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $271,696 in FY2024 (-80.5%), $1.4 million in FY2023 (+132.5%), $600,388 in FY2022 (-53.4%) and $1.29 million in FY2021 (-19.3%).
- The Q4 2025 figure represents the highest quarterly Accounts Payables since Q4 2023.
- Year-over-year, Accounts Payables increased in two of the last eight quarters, with growth averaging 28.5%.
- The fastest year-over-year change in Accounts Payables over five years came in Q4 2025 (growth of 257.7%), and the weakest in Q4 2024 (a decline of 80.5%).
- Business Quant data shows LPCN's Accounts Payables at $861,452 (Q3 2025), $442,994 (Q2 2025) and $360,239 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.40 Bn | 1,140.99 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 642.90 Bn | 561.42 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 375.88 Bn | 330.26 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 302.81 Bn | 266.80 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 268.58 Bn | 242.27 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 242.38 Bn | 197.78 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 193.63 Bn | 167.83 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 172.59 Bn | 119.24 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Lipocine | 8.17 Mn | -59.54 Mn | - | 971,822.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 971,822.00 |
| Sep 30, 2025 | 861,452.00 |
| Jun 30, 2025 | 442,994.00 |
| Mar 31, 2025 | 360,239.00 |
| Dec 31, 2024 | 271,696.00 |
| Sep 30, 2024 | 285,347.00 |
| Jun 30, 2024 | 448,798.00 |
| Mar 31, 2024 | 671,445.00 |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 517,587.00 |
| Mar 31, 2023 | 796,476.00 |
| Dec 31, 2022 | 600,388.00 |
| Sep 30, 2022 | 630,456.00 |
| Jun 30, 2022 | 814,004.00 |
| Mar 31, 2022 | 469,887.00 |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 725,552.00 |
| Jun 30, 2021 | 906,476.00 |
| Mar 31, 2021 | 558,344.00 |
API Access
Lipocine Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();